109 related articles for article (PubMed ID: 8906288)
41. [Eosinophilia-myalgia syndrome].
Kotake S; Kashiwazaki S
Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
[TBL] [Abstract][Full Text] [Related]
42. [Topics on eosinophilia-myalgia syndrome].
Kamatani N
Nihon Naika Gakkai Zasshi; 1991 Nov; 80(11):1782-7. PubMed ID: 1783846
[No Abstract] [Full Text] [Related]
43. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
Hudson JI; Pope HG; Carter WP; Daniels SR
J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and analysis of contaminants in ems-related tryptophan.
Steinhart H; van Wickern B; Meyer K; Simat T
Adv Exp Med Biol; 1996; 398():667-75. PubMed ID: 8906342
[No Abstract] [Full Text] [Related]
45. Use of tryptophanase in the detection of contaminants in EMS related L-tryptophan.
Simat T; Steinhart H
J Pharm Biomed Anal; 1997 Sep; 16(1):167-73. PubMed ID: 9447564
[No Abstract] [Full Text] [Related]
46. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
Sidransky H
Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
[TBL] [Abstract][Full Text] [Related]
47. Use of serotonergic agents in the clinical assessment of central serotonin function.
Murphy DL; Mueller EA; Garrick NA; Aulakh CS
J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
[TBL] [Abstract][Full Text] [Related]
48. [Correction of altered serotonin exchange in adolescents with functional disorders of digestive system].
Mosiienko HP
Lik Sprava; 2012; (1-2):86-9. PubMed ID: 23035605
[TBL] [Abstract][Full Text] [Related]
49. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Shapiro S
J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
[TBL] [Abstract][Full Text] [Related]
50. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
Mensing H; Schallreuter KU; Senff H; Steinkraus V
Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
[TBL] [Abstract][Full Text] [Related]
51. Serotonin and migraine: biology and clinical implications.
Hamel E
Cephalalgia; 2007 Nov; 27(11):1293-300. PubMed ID: 17970989
[TBL] [Abstract][Full Text] [Related]
52. Chronic immune activation in the eosinophilia-myalgia syndrome.
McKinley KL; Harati Y; Schneider LW
Muscle Nerve; 1993 Sep; 16(9):947-51. PubMed ID: 8355725
[TBL] [Abstract][Full Text] [Related]
53. Serotonin and migraine: a reconsideration of the central theory.
Panconesi A
J Headache Pain; 2008 Oct; 9(5):267-76. PubMed ID: 18668197
[TBL] [Abstract][Full Text] [Related]
54. The eosinophilia-myalgia syndrome.
Silver RM
Clin Dermatol; 1994; 12(3):457-65. PubMed ID: 7954203
[No Abstract] [Full Text] [Related]
55. Serotonergic mechanisms in the migraine brain - a systematic review.
Deen M; Christensen CE; Hougaard A; Hansen HD; Knudsen GM; Ashina M
Cephalalgia; 2017 Mar; 37(3):251-264. PubMed ID: 27013238
[TBL] [Abstract][Full Text] [Related]
56. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
Clauw DJ; Pincus T
J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
[No Abstract] [Full Text] [Related]
57. [Migraine and irritable bowel syndrome].
Mulak A; Paradowski L
Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S55-60. PubMed ID: 16419571
[TBL] [Abstract][Full Text] [Related]
58. Use of cyclosporin A in the eosinophilia myalgia syndrome.
Clauw DJ; Alloway JA; Katz P
Ann Rheum Dis; 1993 Jan; 52(1):81-2. PubMed ID: 8427523
[No Abstract] [Full Text] [Related]
59. Eosinophilia-myalgia syndrome. Status of patients at onset and after four years of disease.
Criswell LA; Pincus T
Adv Exp Med Biol; 1996; 398():371-2. PubMed ID: 8906291
[No Abstract] [Full Text] [Related]
60. Painful venous overdistension in migraine and serotonergic parameters.
Saxena P
Cephalalgia; 1996 Feb; 16(1):3. PubMed ID: 8825690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
